Skip to main content

Table 1 Investigatory Pathways. () indicates requirement according to the article protocol. Note the National Temporal Lobectomy Survey [38] was not an individual protocol, hence was not included in the proportion calculations

From: Investigatory pathway and principles of patient selection for epilepsy surgery candidates: a systematic review

Citation

Clinical History

Physical Examination

Scalp Video/EEG Telemetry

Structural MRI

Neuropsychological Assessment

Neuropsychiatric Assessment

Social Care/Nursing Assessment (of support network)

fMRI

Wada Test

[18F] FDG-PET

Ictal SPECT

MEG

Intracranial EEG Electrodes

Realistic Expectation of Outcomes

MR Spectroscopy

Patient Management Conference

Occupational Evaluation

London, England 2011 [14]

Ancillary

Ancillary

Ancillary

Ancillary

Ancillary

Ancillary

   

National Temporal Lobectomy Survey; United States 2009 [39]

    

32–36.8%

  

28.6–36.8%

52–64.7% deemed essential

Considerable variation

Considerable variation

Considerable variation

 

nearly all inform of postoperative deficits

   

Havana, Cuba 2009 [40]

    

   

  

Gainesville, Florida 2009 [41]

 

     

Ancillary

Ancillary

Ancillary

Ancillary

    

Munich, Germany 2009 [42]

 

  

      

Spanish Neurosurgical Society; Spain 2009 [43]

Ancillary

Ancillary

Ancillary

Ancillary

Ancillary

 

Kerala, India 2010 [37]

 

 

Ancillary

  

Cleveland, Ohio 2010 [38]

 

  

 

Ancillary

Ancillary

      

Phoenix, Arizona 2011 [44]

  

   

Ancillary

Ancillary

 

Ancillary

    

Oslo, Norway 2012 [45]

  

Ancillary

Ancillary

Ancillary

Ancillary

Ancillary

  

Toronto, Canada 2012 [46]

  

Ancillary

Ancillary

Ancillary

     

Italian League Against Epilepsy; Italy 2013 [4]

  

 

 

Ancillary

Ancillary

 

Ancillary

    

Ankara, Turkey 2014 [47]

  

 

 

  

Ancillary

 

  

Japan 2016 [48]

 

    

Ancillary

Ancillary

Ancillary

     

Listed as Required

10/13

6/13

13/13

13/13

11/13

7/13

2/13

7/13

6/13

3/13

3/13

0/13

0/13

3/13

2/13

2/13

2/13

Listed as Ancillary

0/13

0/13

0/13

0/13

0/13

0/13

0/13

1/13

2/13

9/13

9/13

6/13

8/13

0/13

1/13

0/13

0/13